PF4 Antikörper
-
- Target Alle PF4 Antikörper anzeigen
- PF4 (Platelet Factor 4 (PF4))
-
Reaktivität
- Human
-
Wirt
-
Schaf
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PF4 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marke
- IHC-plus™
- Spezifität
- Recognizes human PF4.
- Aufreinigung
- Immunoaffinity purified
- Immunogen
- Platelet Factor 4 (PF4) purified from human platelet releasate.
- Isotyp
- IgG
- Top Product
- Discover our top product PF4 Primärantikörper
-
-
- Applikationshinweise
-
Approved: ELISA, IHC, IHC-P (5 μg/mL)
Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 5 μg/mL. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- 0.01 M HEPES, pH 7.4, 0.15 M sodium chloride, 50 % glycerol. No preservative added.
- Konservierungsmittel
- Without preservative
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- 4°C or -20°C, Avoid freeze-thaw cycles.
-
-
Case Report: A Case of COVID Vaccine-Induced Thrombotic Thrombocytopenia Manifested as Pulmonary Embolism and Hemorrhagia. A First Reported Case From Slovakia." in: Frontiers in medicine, Vol. 8, pp. 789972, (2021) (PubMed).
: "
-
Case Report: A Case of COVID Vaccine-Induced Thrombotic Thrombocytopenia Manifested as Pulmonary Embolism and Hemorrhagia. A First Reported Case From Slovakia." in: Frontiers in medicine, Vol. 8, pp. 789972, (2021) (PubMed).
-
- Target
- PF4 (Platelet Factor 4 (PF4))
- Andere Bezeichnung
- CXCL4 / PF4 (PF4 Produkte)
- Synonyme
- CXCL4 antikoerper, PF-4 antikoerper, SCYB4 antikoerper, Cxcl4 antikoerper, Scyb4 antikoerper, Pf4a antikoerper, RATPF4A antikoerper, PF4A antikoerper, CXCL4L1 antikoerper, CXCL4V1 antikoerper, PF4-ALT antikoerper, SCYB4V1 antikoerper, PF4 antikoerper, platelet factor 4 antikoerper, platelet factor 4 variant 1 antikoerper, PF4 antikoerper, Pf4 antikoerper, LOC703451 antikoerper, PF4V1 antikoerper, LOC100524373 antikoerper, LOC102181854 antikoerper, LOC100630489 antikoerper
- Hintergrund
-
Name/Gene ID: PF4
Subfamily: Intercrine alpha
Family: Intercrine
Synonyms: PF4, C-X-C motif chemokine 4, CXCL4, Iroplact, Oncostatin-A, PF-4, SCYB4, Platelet factor 4 - Gen-ID
- 5196
- UniProt
- P02776
-